Sherbrooke Park Advisers LLC Replimune Group, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 10,735 shares of REPL stock, worth $110,033. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,735Holding current value
$110,033% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding REPL
# of Institutions
195Shares Held
77.5MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$113 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$111 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$48.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$47.8 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$40.1 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $505M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...